Tag: Neoadjuvant Chemotherapy
-
MRI May Predict Outcomes in TNBC Treatment with Chemo and Immunotherapy
Overview: MRI as a Tool in TNBC Treatment Triple-negative breast cancer (TNBC) remains one of the most challenging breast cancer subtypes to treat. Recent research suggests that magnetic resonance imaging (MRI) may play a pivotal role in predicting how patients with TNBC will respond to a combination of neoadjuvant chemotherapy and immunotherapy. This could lead…
-
MRI May Predict Outcomes in TNBC Treatment with Neoadjuvant Chemo and Immunotherapy
Understanding the New Findings Triple-negative breast cancer (TNBC) remains a challenging subtype of breast cancer, characterized by the absence of estrogen, progesterone, and HER2 receptors. This makes targeted hormonal therapies ineffective, driving interest in combination approaches such as neoadjuvant chemotherapy paired with immunotherapy. Recent research suggests that magnetic resonance imaging (MRI) could play a pivotal…
-
Study Finds MRI Could Help Predict Outcomes in Triple-Negative Breast Cancer Treatment
Overview: MRI in the Era of Chemo-Immunotherapy for TNBC Triple-negative breast cancer (TNBC) is a challenging subtype that often requires aggressive treatment. Recent studies indicate that magnetic resonance imaging (MRI) may play a valuable role in predicting how patients with TNBC will respond to a combination of neoadjuvant chemotherapy and immunotherapy. This potential diagnostic aid…